chr10-27155399-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001172303.3(MASTL):c.-28C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.624 in 1,575,846 control chromosomes in the GnomAD database, including 309,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.60 ( 27801 hom., cov: 32)
Exomes 𝑓: 0.63 ( 282083 hom. )
Consequence
MASTL
NM_001172303.3 5_prime_UTR
NM_001172303.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.224
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-27155399-C-A is Benign according to our data. Variant chr10-27155399-C-A is described in ClinVar as [Benign]. Clinvar id is 262113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MASTL | NM_001172303.3 | c.-28C>A | 5_prime_UTR_variant | 1/12 | ENST00000375940.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MASTL | ENST00000375940.9 | c.-28C>A | 5_prime_UTR_variant | 1/12 | 1 | NM_001172303.3 | P5 | ||
MASTL | ENST00000375946.8 | c.-28C>A | 5_prime_UTR_variant | 1/12 | 1 | A1 | |||
MASTL | ENST00000342386.10 | c.-28C>A | 5_prime_UTR_variant | 1/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.602 AC: 91400AN: 151786Hom.: 27804 Cov.: 32
GnomAD3 genomes
AF:
AC:
91400
AN:
151786
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.592 AC: 115272AN: 194594Hom.: 34644 AF XY: 0.590 AC XY: 62832AN XY: 106548
GnomAD3 exomes
AF:
AC:
115272
AN:
194594
Hom.:
AF XY:
AC XY:
62832
AN XY:
106548
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.626 AC: 891481AN: 1423946Hom.: 282083 Cov.: 33 AF XY: 0.623 AC XY: 439517AN XY: 705682
GnomAD4 exome
AF:
AC:
891481
AN:
1423946
Hom.:
Cov.:
33
AF XY:
AC XY:
439517
AN XY:
705682
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.602 AC: 91406AN: 151900Hom.: 27801 Cov.: 32 AF XY: 0.601 AC XY: 44600AN XY: 74238
GnomAD4 genome
AF:
AC:
91406
AN:
151900
Hom.:
Cov.:
32
AF XY:
AC XY:
44600
AN XY:
74238
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1549
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Thrombocytopenia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at